These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11965092)

  • 1. [Prevalence of HBV and HCV infections and incidence of HCV infection after 3, 6 and 12 months detention in La Santé prison, Paris].
    Arrada A; Zak Dit Zbar O; Vasseur V
    Ann Med Interne (Paris); 2001 Nov; 152 Suppl 7():6-8. PubMed ID: 11965092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
    J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of hepatitis B and C among prison population in Croatia].
    Burek V; Horvat J; Susić E; Mikulić R
    Acta Med Croatica; 2009 Dec; 63(5):447-50. PubMed ID: 20198906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
    Miller ER; Bi P; Ryan P
    Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of hepatitis C virus (HCV) infection in closed communities].
    Nazare C; Girleanu I; Cojocariu-Salloum C; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):736-41. PubMed ID: 22046780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tattooing in prisons--not such a pretty picture.
    Hellard ME; Aitken CK; Hocking JS
    Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral hepatitis B, C and HIV infection in Croatian prisons.
    Burek V; Horvat J; Butorac K; Mikulić R
    Epidemiol Infect; 2010 Nov; 138(11):1610-20. PubMed ID: 20202285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tattoos, incarceration and hepatitis B and C among street-recruited injection drug users in New Mexico, USA: update.
    Samuel MC; Bulterys M; Jenison S; Doherty P
    Epidemiol Infect; 2005 Dec; 133(6):1146-8. PubMed ID: 16274514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province.
    Mohtasham Amiri Z; Rezvani M; Jafari Shakib R; Jafari Shakib A
    East Mediterr Health J; 2007; 13(2):250-6. PubMed ID: 17684845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of hepatitis B and C in juvenile detention entrants, Oregon, 1994-1996.
    Thomas AR; Keene WE; Cieslak PR
    J Adolesc Health; 2005 Nov; 37(5):410-3. PubMed ID: 16227130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence infections and risk factors due to HIV, Hepatitis B and C in a prison establishment in Leiria].
    Passadouro R
    Acta Med Port; 2004; 17(5):381-4. PubMed ID: 16197845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for viral hepatitis among male non-drug-abuse prisoners.
    Liao KF; Lai SW; Chang WL; Hsu NY
    Scand J Gastroenterol; 2006 Aug; 41(8):969-73. PubMed ID: 16803696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
    Ruan Y; Qin G; Yin L; Chen K; Qian HZ; Hao C; Liang S; Zhu J; Xing H; Hong K; Shao Y
    AIDS; 2007 Dec; 21 Suppl 8():S39-46. PubMed ID: 18172390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening.
    Nelwan EJ; Van Crevel R; Alisjahbana B; Indrati AK; Dwiyana RF; Nuralam N; Pohan HT; Jaya I; Meheus A; Van Der Ven A
    Trop Med Int Health; 2010 Dec; 15(12):1491-8. PubMed ID: 20955370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.
    Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM
    Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.